Are you Dr. Avadhani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 89 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
Suite 320a
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-955-2340
Summary
- Dr. Anjali Avadhani, MD is an oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Thomas Jefferson University Hospital.
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of ChicagoResidency, Internal Medicine, 2001 - 2004
- Perelman School of Medicine at the University of PennsylvaniaClass of 2001
Certifications & Licensure
- PA State Medical License 2004 - 2021
Publications & Presentations
PubMed
- A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.Emiliano Calvo, Bernard Doger, Joan Carles, Avivit Peer, David Sarid
The Oncologist. 2025-01-17 - 7 citationsExposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.Anne-Gaëlle Dosne, Elodie Valade, Nele Goeyvaerts, Peter De Porre, Anjali Avadhani
Cancer Chemotherapy and Pharmacology. 2022-02-01 - 777 citationsErdafitinib in Locally Advanced or Metastatic Urothelial CarcinomaYohann Loriot, Andrea Necchi, Se Hoon Park, Jesús García-Donas, Robert Huddart
The New England Journal of Medicine. 2019-07-24